Cytosorbents Corp
CTSO
77 hedge funds and large institutions have $64.6M invested in Cytosorbents Corp in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 15 closing their positions.
14% more call options, than puts
Call options by funds: $247K | Put options by funds: $216K
13% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 23
0.6% less ownership
Funds ownership: 27.35% → 26.75% (-0.6%)
8% less capital invested
Capital invested by funds: $69.9M → $64.6M (-$5.35M)
9% less funds holding
Funds holding: 85 → 77 (-8)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$1.09M |
| 2 |
Millennium Management
New York
|
+$765K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$516K |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$402K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$370K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$1.57M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$869K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$655K |
| 4 |
Renaissance Technologies
New York
|
-$646K |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$630K |
CTSO Hedge Fund Activity: Q1 2019 in Review
77 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2019, worth a combined $64.6M — down 7.7% from $69.9M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CTSO and 7 opened new positions — a net loss of 8 holders — while 23 trimmed existing stakes and 26 added.
The largest buyer was Skylands Capital, adding an estimated $1.09M. The largest seller was Manatuck Hill Partners, exiting entirely with an estimated $1.57M sold.
- 77 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2019, down from 85 in Q4 2018.
- Funds reported $64.6M of Cytosorbents Corp stock for Q1 2019, down 7.7% quarter-over-quarter.
- 7 funds opened new Cytosorbents Corp positions in Q1 2019 and 15 closed out, a net change of -8 holders.
- The largest Cytosorbents Corp buyer in Q1 2019 was Skylands Capital, an estimated $1.09M added.
- The largest Cytosorbents Corp seller in Q1 2019 was Manatuck Hill Partners, an estimated $1.57M sold.
Based on aggregated 13F filings for Q1 2019.